Helga S. Marques

Locally Advanced Breast Cancer: MR Imaging for Prediction of Response to Neoadjuvant Chemotherapy—Results from ACRIN 6657/I-SPY TRIAL

Nola M. Hylton, Jeffrey D. Blume, Wanda K. Bernreuter et al. · Radiology · 2012 · 489 citations

Medicine, Oncology, Radiology +17

Diffusion-weighted MRI Findings Predict Pathologic Response in Neoadjuvant Treatment of Breast Cancer: The ACRIN 6698 Multicenter Trial

Savannah C. Partridge, Zheng Zhang, David C. Newitt et al. · Radiology · 2018 · 284 citations

Medicine, Oncology, Radiology +17

Neoadjuvant Chemotherapy for Breast Cancer: Functional Tumor Volume by MR Imaging Predicts Recurrence-free Survival—Results from the ACRIN 6657/CALGB 150007 I-SPY 1 TRIAL

Nola M. Hylton, Constantine Gatsonis, Mark Rosen et al. · Radiology · 2015 · 277 citations · Full text

Medicine, Oncology, Radiology +17

The Impact of Positron Emission Tomography with ¹⁸ F-Fluciclovine on the Treatment of Biochemical Recurrence of Prostate Cancer: Results from the LOCATE Trial

Gerald L. Andriole, Lale Kostakoğlu, Albert Chau et al. · The Journal of Urology · 2018 · 150 citations · Full text

Medicine, Nuclear Medicine, Urology +14

MRI, Clinical Examination, and Mammography for Preoperative Assessment of Residual Disease and Pathologic Complete Response After Neoadjuvant Chemotherapy for Breast Cancer: ACRIN 6657 Trial

John R. Scheel, Eunhee Kim, Savannah C. Partridge et al. · American Journal of Roentgenology · 2018 · 128 citations · Full text

Medicine, Oncology, Radiology +17